Company: ELV
Filing Date: 2025-10-21
Form Type: 10-Q
Source: 0001156039-25-000136
Chunk: 45

Company: Elevance Health, Inc.
Filing Date: 2025-10-21
Form: 10-Q
Item: Item 8
Chunk 45
---
 of period balance(199)(205)(207)(211)Other comprehensive income (loss), net of tax benefit (expense) of $1, $0, ($3), and ($2), respectively(3)2 5 8 End of period balance(202)(203)(202)(203)Pension and other postretirement benefits:Beginning of period balance(402)(451)(399)(459)Other comprehensive income, net of tax expense of ($1), ($1), ($10), and ($3), respectively4 3 1 11 End of period balance(398)(448)(398)(448)Future policy benefits:Beginning of period balance9 9 8 10 Other comprehensive loss, net of tax benefit of $0, $0, $0, and $0, respectively(2)(1)(1)(2)End of period balance7 8 7 8 Foreign currency translation adjustments:Beginning of period balance(22)(23)(24)(18)Other comprehensive (loss) income, net of tax expense of $0, $0, $0, and $0, respectively(1)7 1 2 End of period balance(23)(16)(23)(16)Total:Total beginning of period accumulated other comprehensive loss(760)(1,387)(1,147)(1,313)Total other comprehensive income, net of tax expense of ($66), ($281), ($196), and ($259), respectively219 898 608 824 Total other comprehensive income attributable to noncontrolling interests, net of tax expense of $0, $0, $0, and $0, respectively(2)— (4)— Total end of period accumulated other comprehensive loss$(543)$(489)$(543)$(489)

-32-

14.     Shareholders' Earnings per Share

The denominator for basic and diluted shareholders' earnings per share for the three and nine months ended September 30, 2025 and 2024 is as follows: Three Months Ended  September 30Nine Months Ended  September 30 2025202420252024Denominator for basic shareholders' earnings per share – weighted-average shares223.3 231.9 225.0 232.3 Effect of dilutive securities – employee stock options, non-vested restricted stock awards and convertible debentures0.4 1.2 0.6 1.3 Denominator for diluted shareholders